Physician profile
James F Appleton
NPI 1710280037
$9,679.09
in general payments reported to CMS, 2019-2025
39 companies · $625 in 2025
The $625 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,574 · 2020: $2,790 · 2021: $741 · 2022: $1,180 · 2023: $1,581 · 2024: $1,187 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,973 · Travel and Lodging: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,972.78 |
| Travel and Lodging | $420.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kairos Surgical INC | $2,201.17 | 2020-2023 | |
| Smith+Nephew, INC. | $1,494.20 | 2019-2025 | Collagenase Santyl, Iodosorb Ointment 40g USA, Renasys Touch |
| Zimmer Biomet Holdings, INC. | $1,018.53 | 2019-2023 | Tapestry, Nextremity General Instrument, Accufill |
| Biotissue Holdings INC. | $680.07 | 2022-2024 | |
| Treace Medical Concepts, INC. | $564.44 | 2022-2025 | |
| Stryker Corporation | $478.47 | 2021-2025 | Prophecy, Prostep, Prostep Mica |
| Paratek Pharmaceuticals, INC. | $469.44 | 2021-2025 | Nuzyra |
| Integra Lifesciences Corporation | $462.65 | 2019-2020 | |
| Horizon Therapeutics Plc | $226.79 | 2019-2020 | |
| Kerecis Limited | $195.67 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| International Life Sciences | $180.98 | 2024 | Flexband |
| Innovation Technologies INC | $170.06 | 2025 | Irrisept |
| Orthofix Medical, INC. | $124.48 | 2021-2023 | Physio-Stim |
| Vaporox, INC. | $118.35 | 2023 | Vht-200 Wound Treatment System |
| Melinta Therapeutics, LLC | $114.54 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $111.84 | 2019 | |
| Abbvie INC. | $106.59 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $105.02 | 2023-2025 | Purified Cortrophin Gel |
| Medtronic Vascular, INC. | $100.12 | 2019 | |
| Organogenesis INC. | $80.24 | 2020-2021 | |
| Misonix INC | $79.06 | 2021 | |
| Nevro Corp. | $72.68 | 2022-2023 | Senza |
| Kci USA, INC. | $61.72 | 2019-2022 | |
| Acell, INC. | $60.00 | 2020 | |
| Bioventus LLC | $52.70 | 2020-2022 | |
| Zyla Life Sciences, INC. | $49.25 | 2019 | |
| Lifenet Health | $44.93 | 2024-2025 | Theragenesis Wound Matrix |
| Sebela Pharmaceuticals INC. | $41.47 | 2021-2023 | Naftin |
| Alfasigma USA, INC. | $31.36 | 2020-2021 | |
| Ibsa Pharma INC. | $30.16 | 2023 | Tirosint, Licart |
| Hydrofera LLC | $27.06 | 2025 | Hydrofera Blue |
| Mimedx Group, INC. | $19.94 | 2025 | |
| Medtronic, INC. | $19.02 | 2025 | Closurefast |
| Biocomposites INC | $18.51 | 2021 | |
| Reprise Biomedical, INC. | $15.15 | 2023 | Miroderm, Miro3d |
| Dynasplint Systems INC. | $14.14 | 2019 | |
| Polynovo North America LLC | $13.92 | 2023 | |
| Djo, LLC | $12.99 | 2023 | Dr Comfort |
| Pfizer INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Appleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.